Status:
COMPLETED
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
Lead Sponsor:
National Taipei University of Nursing and Health Sciences
Conditions:
Schizophrenia
Eligibility:
All Genders
20-99 years
Phase:
NA
Brief Summary
This was a randomized controlled behavioral intervention trial to assess the efficacy of investigating program of chronic disease self-management program in people on schizophrenia patients conditions...
Detailed Description
Subjects were randomized to intervention group and control group. The primary outcome included eight measures, Stanford Self-Management Questionnaire, the Beck Depression Inventory-II, the Activities ...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia by DSM-5
- age \> 20 years
- Stable mental symptoms
- Willing to sign the subject's consent
Exclusion
- History of severe brain injury
- Substance abuse
- Diagnosis of intellectual developmental disorder
- Unable to follow instructions
Key Trial Info
Start Date :
September 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 25 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04503954
Start Date
September 7 2020
End Date
December 25 2020
Last Update
November 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taipei University of Nursing and Health Sciences
Taipei, Wanhua Dist, Taiwan, 108306